Sign inGet started

Piper Brian

Insider CIK 1665924 · MDGN Chief Financial Officer · PRLD Chief Financial Officer · SANA EVP, Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SANA Sana Biotechnology, Inc. A Award deriv2026-02-172026-02-18900,000— $0900,000SEC↗
SANA Sana Biotechnology, Inc. A Award deriv2026-02-172026-02-18200,000— $0200,000SEC↗
PRLD Prelude Therapeutics Inc M Exercise deriv2021-08-252021-08-278,333— $0264,329SEC↗
PRLD Prelude Therapeutics Inc S Sale2021-08-252021-08-273,889$33.23 $129.2K2,344SEC↗
PRLD Prelude Therapeutics Inc S Sale2021-08-252021-08-272,100$32.44 $68.1K6,233SEC↗
PRLD Prelude Therapeutics Inc M Exercise2021-08-252021-08-278,333$1.89 $15.7K8,333SEC↗
PRLD Prelude Therapeutics Inc S Sale2021-08-252021-08-272,344$34.33 $80.5K0SEC↗
PRLD Prelude Therapeutics Inc A Award deriv2021-07-202021-07-22115,650— $0115,650SEC↗
PRLD Prelude Therapeutics Inc M Exercise deriv2021-05-252021-05-278,333— $0272,662SEC↗
PRLD Prelude Therapeutics Inc S Sale2021-05-252021-05-271,736$35.45 $61.5K399SEC↗
PRLD Prelude Therapeutics Inc M Exercise2021-05-252021-05-278,333$1.89 $15.7K8,333SEC↗
PRLD Prelude Therapeutics Inc S Sale2021-05-252021-05-273,088$34.11 $105.3K2,135SEC↗
PRLD Prelude Therapeutics Inc S Sale2021-05-252021-05-27399$36.09 $14.4K0SEC↗
PRLD Prelude Therapeutics Inc S Sale2021-05-252021-05-273,110$33.53 $104.3K5,223SEC↗
GNMX Aevi Genomic Medicine, Inc A Award deriv2018-06-142018-06-18238,000— $0238,000SEC↗
GNMX Aevi Genomic Medicine, Inc A Award deriv2018-05-142018-05-16270,000— $0270,000SEC↗
GNMX Aevi Genomic Medicine, Inc A Award deriv2017-08-112018-05-16110,000— $0110,000SEC↗
GNMX Aevi Genomic Medicine, Inc A Award deriv2017-08-112017-08-15380,000— $0380,000SEC↗
GNMX Aevi Genomic Medicine, Inc A Award deriv2017-02-172017-02-17190,000— $0190,000SEC↗
MDGN MEDGENICS, INC. A Award deriv2016-04-152016-04-19150,000— $0150,000SEC↗